1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Gliclazide Sustained-release Tablet Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Gliclazide Sustained-release Tablet by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Gliclazide Sustained-release Tablet by Country/Region, 2018, 2022 & 2029
2.2 Gliclazide Sustained-release Tablet Segment by Type
2.2.1 30mg
2.2.2 60mg
2.2.3 Other
2.3 Gliclazide Sustained-release Tablet Sales by Type
2.3.1 Global Gliclazide Sustained-release Tablet Sales Market Share by Type (2018-2023)
2.3.2 Global Gliclazide Sustained-release Tablet Revenue and Market Share by Type (2018-2023)
2.3.3 Global Gliclazide Sustained-release Tablet Sale Price by Type (2018-2023)
2.4 Gliclazide Sustained-release Tablet Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 Gliclazide Sustained-release Tablet Sales by Application
2.5.1 Global Gliclazide Sustained-release Tablet Sale Market Share by Application (2018-2023)
2.5.2 Global Gliclazide Sustained-release Tablet Revenue and Market Share by Application (2018-2023)
2.5.3 Global Gliclazide Sustained-release Tablet Sale Price by Application (2018-2023)
3 Global Gliclazide Sustained-release Tablet by Company
3.1 Global Gliclazide Sustained-release Tablet Breakdown Data by Company
3.1.1 Global Gliclazide Sustained-release Tablet Annual Sales by Company (2018-2023)
3.1.2 Global Gliclazide Sustained-release Tablet Sales Market Share by Company (2018-2023)
3.2 Global Gliclazide Sustained-release Tablet Annual Revenue by Company (2018-2023)
3.2.1 Global Gliclazide Sustained-release Tablet Revenue by Company (2018-2023)
3.2.2 Global Gliclazide Sustained-release Tablet Revenue Market Share by Company (2018-2023)
3.3 Global Gliclazide Sustained-release Tablet Sale Price by Company
3.4 Key Manufacturers Gliclazide Sustained-release Tablet Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Gliclazide Sustained-release Tablet Product Location Distribution
3.4.2 Players Gliclazide Sustained-release Tablet Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Gliclazide Sustained-release Tablet by Geographic Region
4.1 World Historic Gliclazide Sustained-release Tablet Market Size by Geographic Region (2018-2023)
4.1.1 Global Gliclazide Sustained-release Tablet Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Gliclazide Sustained-release Tablet Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Gliclazide Sustained-release Tablet Market Size by Country/Region (2018-2023)
4.2.1 Global Gliclazide Sustained-release Tablet Annual Sales by Country/Region (2018-2023)
4.2.2 Global Gliclazide Sustained-release Tablet Annual Revenue by Country/Region (2018-2023)
4.3 Americas Gliclazide Sustained-release Tablet Sales Growth
4.4 APAC Gliclazide Sustained-release Tablet Sales Growth
4.5 Europe Gliclazide Sustained-release Tablet Sales Growth
4.6 Middle East & Africa Gliclazide Sustained-release Tablet Sales Growth
5 Americas
5.1 Americas Gliclazide Sustained-release Tablet Sales by Country
5.1.1 Americas Gliclazide Sustained-release Tablet Sales by Country (2018-2023)
5.1.2 Americas Gliclazide Sustained-release Tablet Revenue by Country (2018-2023)
5.2 Americas Gliclazide Sustained-release Tablet Sales by Type
5.3 Americas Gliclazide Sustained-release Tablet Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Gliclazide Sustained-release Tablet Sales by Region
6.1.1 APAC Gliclazide Sustained-release Tablet Sales by Region (2018-2023)
6.1.2 APAC Gliclazide Sustained-release Tablet Revenue by Region (2018-2023)
6.2 APAC Gliclazide Sustained-release Tablet Sales by Type
6.3 APAC Gliclazide Sustained-release Tablet Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Gliclazide Sustained-release Tablet by Country
7.1.1 Europe Gliclazide Sustained-release Tablet Sales by Country (2018-2023)
7.1.2 Europe Gliclazide Sustained-release Tablet Revenue by Country (2018-2023)
7.2 Europe Gliclazide Sustained-release Tablet Sales by Type
7.3 Europe Gliclazide Sustained-release Tablet Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Gliclazide Sustained-release Tablet by Country
8.1.1 Middle East & Africa Gliclazide Sustained-release Tablet Sales by Country (2018-2023)
8.1.2 Middle East & Africa Gliclazide Sustained-release Tablet Revenue by Country (2018-2023)
8.2 Middle East & Africa Gliclazide Sustained-release Tablet Sales by Type
8.3 Middle East & Africa Gliclazide Sustained-release Tablet Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Gliclazide Sustained-release Tablet
10.3 Manufacturing Process Analysis of Gliclazide Sustained-release Tablet
10.4 Industry Chain Structure of Gliclazide Sustained-release Tablet
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Gliclazide Sustained-release Tablet Distributors
11.3 Gliclazide Sustained-release Tablet Customer
12 World Forecast Review for Gliclazide Sustained-release Tablet by Geographic Region
12.1 Global Gliclazide Sustained-release Tablet Market Size Forecast by Region
12.1.1 Global Gliclazide Sustained-release Tablet Forecast by Region (2024-2029)
12.1.2 Global Gliclazide Sustained-release Tablet Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Gliclazide Sustained-release Tablet Forecast by Type
12.7 Global Gliclazide Sustained-release Tablet Forecast by Application
13 Key Players Analysis
13.1 Servier Laboratories
13.1.1 Servier Laboratories Company Information
13.1.2 Servier Laboratories Gliclazide Sustained-release Tablet Product Portfolios and Specifications
13.1.3 Servier Laboratories Gliclazide Sustained-release Tablet Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Servier Laboratories Main Business Overview
13.1.5 Servier Laboratories Latest Developments
13.2 Torrent Pharmaceuticals
13.2.1 Torrent Pharmaceuticals Company Information
13.2.2 Torrent Pharmaceuticals Gliclazide Sustained-release Tablet Product Portfolios and Specifications
13.2.3 Torrent Pharmaceuticals Gliclazide Sustained-release Tablet Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Torrent Pharmaceuticals Main Business Overview
13.2.5 Torrent Pharmaceuticals Latest Developments
13.3 Aurobindo Pharma
13.3.1 Aurobindo Pharma Company Information
13.3.2 Aurobindo Pharma Gliclazide Sustained-release Tablet Product Portfolios and Specifications
13.3.3 Aurobindo Pharma Gliclazide Sustained-release Tablet Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Aurobindo Pharma Main Business Overview
13.3.5 Aurobindo Pharma Latest Developments
13.4 Teva
13.4.1 Teva Company Information
13.4.2 Teva Gliclazide Sustained-release Tablet Product Portfolios and Specifications
13.4.3 Teva Gliclazide Sustained-release Tablet Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Teva Main Business Overview
13.4.5 Teva Latest Developments
13.5 Zydus Cadila Healthcare
13.5.1 Zydus Cadila Healthcare Company Information
13.5.2 Zydus Cadila Healthcare Gliclazide Sustained-release Tablet Product Portfolios and Specifications
13.5.3 Zydus Cadila Healthcare Gliclazide Sustained-release Tablet Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Zydus Cadila Healthcare Main Business Overview
13.5.5 Zydus Cadila Healthcare Latest Developments
13.6 Sanofi S.A.
13.6.1 Sanofi S.A. Company Information
13.6.2 Sanofi S.A. Gliclazide Sustained-release Tablet Product Portfolios and Specifications
13.6.3 Sanofi S.A. Gliclazide Sustained-release Tablet Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Sanofi S.A. Main Business Overview
13.6.5 Sanofi S.A. Latest Developments
13.7 Mylan Pharmaceuticals
13.7.1 Mylan Pharmaceuticals Company Information
13.7.2 Mylan Pharmaceuticals Gliclazide Sustained-release Tablet Product Portfolios and Specifications
13.7.3 Mylan Pharmaceuticals Gliclazide Sustained-release Tablet Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Mylan Pharmaceuticals Main Business Overview
13.7.5 Mylan Pharmaceuticals Latest Developments
13.8 Accord Healthcare
13.8.1 Accord Healthcare Company Information
13.8.2 Accord Healthcare Gliclazide Sustained-release Tablet Product Portfolios and Specifications
13.8.3 Accord Healthcare Gliclazide Sustained-release Tablet Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Accord Healthcare Main Business Overview
13.8.5 Accord Healthcare Latest Developments
13.9 Lukang Jituan Saite Yaoye
13.9.1 Lukang Jituan Saite Yaoye Company Information
13.9.2 Lukang Jituan Saite Yaoye Gliclazide Sustained-release Tablet Product Portfolios and Specifications
13.9.3 Lukang Jituan Saite Yaoye Gliclazide Sustained-release Tablet Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Lukang Jituan Saite Yaoye Main Business Overview
13.9.5 Lukang Jituan Saite Yaoye Latest Developments
13.10 Shijiazhuang SIYAO
13.10.1 Shijiazhuang SIYAO Company Information
13.10.2 Shijiazhuang SIYAO Gliclazide Sustained-release Tablet Product Portfolios and Specifications
13.10.3 Shijiazhuang SIYAO Gliclazide Sustained-release Tablet Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Shijiazhuang SIYAO Main Business Overview
13.10.5 Shijiazhuang SIYAO Latest Developments
13.11 Yiling Pharmaceutical
13.11.1 Yiling Pharmaceutical Company Information
13.11.2 Yiling Pharmaceutical Gliclazide Sustained-release Tablet Product Portfolios and Specifications
13.11.3 Yiling Pharmaceutical Gliclazide Sustained-release Tablet Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Yiling Pharmaceutical Main Business Overview
13.11.5 Yiling Pharmaceutical Latest Developments
14 Research Findings and Conclusion
Table 1. Gliclazide Sustained-release Tablet Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Gliclazide Sustained-release Tablet Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of 30mg
Table 4. Major Players of 60mg
Table 5. Major Players of Other
Table 6. Global Gliclazide Sustained-release Tablet Sales by Type (2018-2023) & (K Units)
Table 7. Global Gliclazide Sustained-release Tablet Sales Market Share by Type (2018-2023)
Table 8. Global Gliclazide Sustained-release Tablet Revenue by Type (2018-2023) & ($ million)
Table 9. Global Gliclazide Sustained-release Tablet Revenue Market Share by Type (2018-2023)
Table 10. Global Gliclazide Sustained-release Tablet Sale Price by Type (2018-2023) & (US$/Unit)
Table 11. Global Gliclazide Sustained-release Tablet Sales by Application (2018-2023) & (K Units)
Table 12. Global Gliclazide Sustained-release Tablet Sales Market Share by Application (2018-2023)
Table 13. Global Gliclazide Sustained-release Tablet Revenue by Application (2018-2023)
Table 14. Global Gliclazide Sustained-release Tablet Revenue Market Share by Application (2018-2023)
Table 15. Global Gliclazide Sustained-release Tablet Sale Price by Application (2018-2023) & (US$/Unit)
Table 16. Global Gliclazide Sustained-release Tablet Sales by Company (2018-2023) & (K Units)
Table 17. Global Gliclazide Sustained-release Tablet Sales Market Share by Company (2018-2023)
Table 18. Global Gliclazide Sustained-release Tablet Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Gliclazide Sustained-release Tablet Revenue Market Share by Company (2018-2023)
Table 20. Global Gliclazide Sustained-release Tablet Sale Price by Company (2018-2023) & (US$/Unit)
Table 21. Key Manufacturers Gliclazide Sustained-release Tablet Producing Area Distribution and Sales Area
Table 22. Players Gliclazide Sustained-release Tablet Products Offered
Table 23. Gliclazide Sustained-release Tablet Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Gliclazide Sustained-release Tablet Sales by Geographic Region (2018-2023) & (K Units)
Table 27. Global Gliclazide Sustained-release Tablet Sales Market Share Geographic Region (2018-2023)
Table 28. Global Gliclazide Sustained-release Tablet Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Gliclazide Sustained-release Tablet Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Gliclazide Sustained-release Tablet Sales by Country/Region (2018-2023) & (K Units)
Table 31. Global Gliclazide Sustained-release Tablet Sales Market Share by Country/Region (2018-2023)
Table 32. Global Gliclazide Sustained-release Tablet Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Gliclazide Sustained-release Tablet Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Gliclazide Sustained-release Tablet Sales by Country (2018-2023) & (K Units)
Table 35. Americas Gliclazide Sustained-release Tablet Sales Market Share by Country (2018-2023)
Table 36. Americas Gliclazide Sustained-release Tablet Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Gliclazide Sustained-release Tablet Revenue Market Share by Country (2018-2023)
Table 38. Americas Gliclazide Sustained-release Tablet Sales by Type (2018-2023) & (K Units)
Table 39. Americas Gliclazide Sustained-release Tablet Sales by Application (2018-2023) & (K Units)
Table 40. APAC Gliclazide Sustained-release Tablet Sales by Region (2018-2023) & (K Units)
Table 41. APAC Gliclazide Sustained-release Tablet Sales Market Share by Region (2018-2023)
Table 42. APAC Gliclazide Sustained-release Tablet Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Gliclazide Sustained-release Tablet Revenue Market Share by Region (2018-2023)
Table 44. APAC Gliclazide Sustained-release Tablet Sales by Type (2018-2023) & (K Units)
Table 45. APAC Gliclazide Sustained-release Tablet Sales by Application (2018-2023) & (K Units)
Table 46. Europe Gliclazide Sustained-release Tablet Sales by Country (2018-2023) & (K Units)
Table 47. Europe Gliclazide Sustained-release Tablet Sales Market Share by Country (2018-2023)
Table 48. Europe Gliclazide Sustained-release Tablet Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Gliclazide Sustained-release Tablet Revenue Market Share by Country (2018-2023)
Table 50. Europe Gliclazide Sustained-release Tablet Sales by Type (2018-2023) & (K Units)
Table 51. Europe Gliclazide Sustained-release Tablet Sales by Application (2018-2023) & (K Units)
Table 52. Middle East & Africa Gliclazide Sustained-release Tablet Sales by Country (2018-2023) & (K Units)
Table 53. Middle East & Africa Gliclazide Sustained-release Tablet Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Gliclazide Sustained-release Tablet Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Gliclazide Sustained-release Tablet Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Gliclazide Sustained-release Tablet Sales by Type (2018-2023) & (K Units)
Table 57. Middle East & Africa Gliclazide Sustained-release Tablet Sales by Application (2018-2023) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Gliclazide Sustained-release Tablet
Table 59. Key Market Challenges & Risks of Gliclazide Sustained-release Tablet
Table 60. Key Industry Trends of Gliclazide Sustained-release Tablet
Table 61. Gliclazide Sustained-release Tablet Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Gliclazide Sustained-release Tablet Distributors List
Table 64. Gliclazide Sustained-release Tablet Customer List
Table 65. Global Gliclazide Sustained-release Tablet Sales Forecast by Region (2024-2029) & (K Units)
Table 66. Global Gliclazide Sustained-release Tablet Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Gliclazide Sustained-release Tablet Sales Forecast by Country (2024-2029) & (K Units)
Table 68. Americas Gliclazide Sustained-release Tablet Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Gliclazide Sustained-release Tablet Sales Forecast by Region (2024-2029) & (K Units)
Table 70. APAC Gliclazide Sustained-release Tablet Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Gliclazide Sustained-release Tablet Sales Forecast by Country (2024-2029) & (K Units)
Table 72. Europe Gliclazide Sustained-release Tablet Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Gliclazide Sustained-release Tablet Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Middle East & Africa Gliclazide Sustained-release Tablet Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Gliclazide Sustained-release Tablet Sales Forecast by Type (2024-2029) & (K Units)
Table 76. Global Gliclazide Sustained-release Tablet Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Gliclazide Sustained-release Tablet Sales Forecast by Application (2024-2029) & (K Units)
Table 78. Global Gliclazide Sustained-release Tablet Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. Servier Laboratories Basic Information, Gliclazide Sustained-release Tablet Manufacturing Base, Sales Area and Its Competitors
Table 80. Servier Laboratories Gliclazide Sustained-release Tablet Product Portfolios and Specifications
Table 81. Servier Laboratories Gliclazide Sustained-release Tablet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 82. Servier Laboratories Main Business
Table 83. Servier Laboratories Latest Developments
Table 84. Torrent Pharmaceuticals Basic Information, Gliclazide Sustained-release Tablet Manufacturing Base, Sales Area and Its Competitors
Table 85. Torrent Pharmaceuticals Gliclazide Sustained-release Tablet Product Portfolios and Specifications
Table 86. Torrent Pharmaceuticals Gliclazide Sustained-release Tablet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 87. Torrent Pharmaceuticals Main Business
Table 88. Torrent Pharmaceuticals Latest Developments
Table 89. Aurobindo Pharma Basic Information, Gliclazide Sustained-release Tablet Manufacturing Base, Sales Area and Its Competitors
Table 90. Aurobindo Pharma Gliclazide Sustained-release Tablet Product Portfolios and Specifications
Table 91. Aurobindo Pharma Gliclazide Sustained-release Tablet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 92. Aurobindo Pharma Main Business
Table 93. Aurobindo Pharma Latest Developments
Table 94. Teva Basic Information, Gliclazide Sustained-release Tablet Manufacturing Base, Sales Area and Its Competitors
Table 95. Teva Gliclazide Sustained-release Tablet Product Portfolios and Specifications
Table 96. Teva Gliclazide Sustained-release Tablet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 97. Teva Main Business
Table 98. Teva Latest Developments
Table 99. Zydus Cadila Healthcare Basic Information, Gliclazide Sustained-release Tablet Manufacturing Base, Sales Area and Its Competitors
Table 100. Zydus Cadila Healthcare Gliclazide Sustained-release Tablet Product Portfolios and Specifications
Table 101. Zydus Cadila Healthcare Gliclazide Sustained-release Tablet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 102. Zydus Cadila Healthcare Main Business
Table 103. Zydus Cadila Healthcare Latest Developments
Table 104. Sanofi S.A. Basic Information, Gliclazide Sustained-release Tablet Manufacturing Base, Sales Area and Its Competitors
Table 105. Sanofi S.A. Gliclazide Sustained-release Tablet Product Portfolios and Specifications
Table 106. Sanofi S.A. Gliclazide Sustained-release Tablet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 107. Sanofi S.A. Main Business
Table 108. Sanofi S.A. Latest Developments
Table 109. Mylan Pharmaceuticals Basic Information, Gliclazide Sustained-release Tablet Manufacturing Base, Sales Area and Its Competitors
Table 110. Mylan Pharmaceuticals Gliclazide Sustained-release Tablet Product Portfolios and Specifications
Table 111. Mylan Pharmaceuticals Gliclazide Sustained-release Tablet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 112. Mylan Pharmaceuticals Main Business
Table 113. Mylan Pharmaceuticals Latest Developments
Table 114. Accord Healthcare Basic Information, Gliclazide Sustained-release Tablet Manufacturing Base, Sales Area and Its Competitors
Table 115. Accord Healthcare Gliclazide Sustained-release Tablet Product Portfolios and Specifications
Table 116. Accord Healthcare Gliclazide Sustained-release Tablet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 117. Accord Healthcare Main Business
Table 118. Accord Healthcare Latest Developments
Table 119. Lukang Jituan Saite Yaoye Basic Information, Gliclazide Sustained-release Tablet Manufacturing Base, Sales Area and Its Competitors
Table 120. Lukang Jituan Saite Yaoye Gliclazide Sustained-release Tablet Product Portfolios and Specifications
Table 121. Lukang Jituan Saite Yaoye Gliclazide Sustained-release Tablet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 122. Lukang Jituan Saite Yaoye Main Business
Table 123. Lukang Jituan Saite Yaoye Latest Developments
Table 124. Shijiazhuang SIYAO Basic Information, Gliclazide Sustained-release Tablet Manufacturing Base, Sales Area and Its Competitors
Table 125. Shijiazhuang SIYAO Gliclazide Sustained-release Tablet Product Portfolios and Specifications
Table 126. Shijiazhuang SIYAO Gliclazide Sustained-release Tablet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 127. Shijiazhuang SIYAO Main Business
Table 128. Shijiazhuang SIYAO Latest Developments
Table 129. Yiling Pharmaceutical Basic Information, Gliclazide Sustained-release Tablet Manufacturing Base, Sales Area and Its Competitors
Table 130. Yiling Pharmaceutical Gliclazide Sustained-release Tablet Product Portfolios and Specifications
Table 131. Yiling Pharmaceutical Gliclazide Sustained-release Tablet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 132. Yiling Pharmaceutical Main Business
Table 133. Yiling Pharmaceutical Latest Developments
List of Figures
Figure 1. Picture of Gliclazide Sustained-release Tablet
Figure 2. Gliclazide Sustained-release Tablet Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Gliclazide Sustained-release Tablet Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Gliclazide Sustained-release Tablet Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Gliclazide Sustained-release Tablet Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of 30mg
Figure 10. Product Picture of 60mg
Figure 11. Product Picture of Other
Figure 12. Global Gliclazide Sustained-release Tablet Sales Market Share by Type in 2022
Figure 13. Global Gliclazide Sustained-release Tablet Revenue Market Share by Type (2018-2023)
Figure 14. Gliclazide Sustained-release Tablet Consumed in Hospital
Figure 15. Global Gliclazide Sustained-release Tablet Market: Hospital (2018-2023) & (K Units)
Figure 16. Gliclazide Sustained-release Tablet Consumed in Clinic
Figure 17. Global Gliclazide Sustained-release Tablet Market: Clinic (2018-2023) & (K Units)
Figure 18. Gliclazide Sustained-release Tablet Consumed in Other
Figure 19. Global Gliclazide Sustained-release Tablet Market: Other (2018-2023) & (K Units)
Figure 20. Global Gliclazide Sustained-release Tablet Sales Market Share by Application (2022)
Figure 21. Global Gliclazide Sustained-release Tablet Revenue Market Share by Application in 2022
Figure 22. Gliclazide Sustained-release Tablet Sales Market by Company in 2022 (K Units)
Figure 23. Global Gliclazide Sustained-release Tablet Sales Market Share by Company in 2022
Figure 24. Gliclazide Sustained-release Tablet Revenue Market by Company in 2022 ($ Million)
Figure 25. Global Gliclazide Sustained-release Tablet Revenue Market Share by Company in 2022
Figure 26. Global Gliclazide Sustained-release Tablet Sales Market Share by Geographic Region (2018-2023)
Figure 27. Global Gliclazide Sustained-release Tablet Revenue Market Share by Geographic Region in 2022
Figure 28. Americas Gliclazide Sustained-release Tablet Sales 2018-2023 (K Units)
Figure 29. Americas Gliclazide Sustained-release Tablet Revenue 2018-2023 ($ Millions)
Figure 30. APAC Gliclazide Sustained-release Tablet Sales 2018-2023 (K Units)
Figure 31. APAC Gliclazide Sustained-release Tablet Revenue 2018-2023 ($ Millions)
Figure 32. Europe Gliclazide Sustained-release Tablet Sales 2018-2023 (K Units)
Figure 33. Europe Gliclazide Sustained-release Tablet Revenue 2018-2023 ($ Millions)
Figure 34. Middle East & Africa Gliclazide Sustained-release Tablet Sales 2018-2023 (K Units)
Figure 35. Middle East & Africa Gliclazide Sustained-release Tablet Revenue 2018-2023 ($ Millions)
Figure 36. Americas Gliclazide Sustained-release Tablet Sales Market Share by Country in 2022
Figure 37. Americas Gliclazide Sustained-release Tablet Revenue Market Share by Country in 2022
Figure 38. Americas Gliclazide Sustained-release Tablet Sales Market Share by Type (2018-2023)
Figure 39. Americas Gliclazide Sustained-release Tablet Sales Market Share by Application (2018-2023)
Figure 40. United States Gliclazide Sustained-release Tablet Revenue Growth 2018-2023 ($ Millions)
Figure 41. Canada Gliclazide Sustained-release Tablet Revenue Growth 2018-2023 ($ Millions)
Figure 42. Mexico Gliclazide Sustained-release Tablet Revenue Growth 2018-2023 ($ Millions)
Figure 43. Brazil Gliclazide Sustained-release Tablet Revenue Growth 2018-2023 ($ Millions)
Figure 44. APAC Gliclazide Sustained-release Tablet Sales Market Share by Region in 2022
Figure 45. APAC Gliclazide Sustained-release Tablet Revenue Market Share by Regions in 2022
Figure 46. APAC Gliclazide Sustained-release Tablet Sales Market Share by Type (2018-2023)
Figure 47. APAC Gliclazide Sustained-release Tablet Sales Market Share by Application (2018-2023)
Figure 48. China Gliclazide Sustained-release Tablet Revenue Growth 2018-2023 ($ Millions)
Figure 49. Japan Gliclazide Sustained-release Tablet Revenue Growth 2018-2023 ($ Millions)
Figure 50. South Korea Gliclazide Sustained-release Tablet Revenue Growth 2018-2023 ($ Millions)
Figure 51. Southeast Asia Gliclazide Sustained-release Tablet Revenue Growth 2018-2023 ($ Millions)
Figure 52. India Gliclazide Sustained-release Tablet Revenue Growth 2018-2023 ($ Millions)
Figure 53. Australia Gliclazide Sustained-release Tablet Revenue Growth 2018-2023 ($ Millions)
Figure 54. China Taiwan Gliclazide Sustained-release Tablet Revenue Growth 2018-2023 ($ Millions)
Figure 55. Europe Gliclazide Sustained-release Tablet Sales Market Share by Country in 2022
Figure 56. Europe Gliclazide Sustained-release Tablet Revenue Market Share by Country in 2022
Figure 57. Europe Gliclazide Sustained-release Tablet Sales Market Share by Type (2018-2023)
Figure 58. Europe Gliclazide Sustained-release Tablet Sales Market Share by Application (2018-2023)
Figure 59. Germany Gliclazide Sustained-release Tablet Revenue Growth 2018-2023 ($ Millions)
Figure 60. France Gliclazide Sustained-release Tablet Revenue Growth 2018-2023 ($ Millions)
Figure 61. UK Gliclazide Sustained-release Tablet Revenue Growth 2018-2023 ($ Millions)
Figure 62. Italy Gliclazide Sustained-release Tablet Revenue Growth 2018-2023 ($ Millions)
Figure 63. Russia Gliclazide Sustained-release Tablet Revenue Growth 2018-2023 ($ Millions)
Figure 64. Middle East & Africa Gliclazide Sustained-release Tablet Sales Market Share by Country in 2022
Figure 65. Middle East & Africa Gliclazide Sustained-release Tablet Revenue Market Share by Country in 2022
Figure 66. Middle East & Africa Gliclazide Sustained-release Tablet Sales Market Share by Type (2018-2023)
Figure 67. Middle East & Africa Gliclazide Sustained-release Tablet Sales Market Share by Application (2018-2023)
Figure 68. Egypt Gliclazide Sustained-release Tablet Revenue Growth 2018-2023 ($ Millions)
Figure 69. South Africa Gliclazide Sustained-release Tablet Revenue Growth 2018-2023 ($ Millions)
Figure 70. Israel Gliclazide Sustained-release Tablet Revenue Growth 2018-2023 ($ Millions)
Figure 71. Turkey Gliclazide Sustained-release Tablet Revenue Growth 2018-2023 ($ Millions)
Figure 72. GCC Country Gliclazide Sustained-release Tablet Revenue Growth 2018-2023 ($ Millions)
Figure 73. Manufacturing Cost Structure Analysis of Gliclazide Sustained-release Tablet in 2022
Figure 74. Manufacturing Process Analysis of Gliclazide Sustained-release Tablet
Figure 75. Industry Chain Structure of Gliclazide Sustained-release Tablet
Figure 76. Channels of Distribution
Figure 77. Global Gliclazide Sustained-release Tablet Sales Market Forecast by Region (2024-2029)
Figure 78. Global Gliclazide Sustained-release Tablet Revenue Market Share Forecast by Region (2024-2029)
Figure 79. Global Gliclazide Sustained-release Tablet Sales Market Share Forecast by Type (2024-2029)
Figure 80. Global Gliclazide Sustained-release Tablet Revenue Market Share Forecast by Type (2024-2029)
Figure 81. Global Gliclazide Sustained-release Tablet Sales Market Share Forecast by Application (2024-2029)
Figure 82. Global Gliclazide Sustained-release Tablet Revenue Market Share Forecast by Application (2024-2029)
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
